NAMPT and experimental autoimmune encephalomyelitis: Bruzzone et al. also found that catastrophic NAD+ depletion in activated T lymphocytes through NAMPT inhibitor FK866 reduced demyelination and disability in experimental autoimmune encephalomyelitis.